Pilot study [Power / Sample Size]
» […] Chloropyramine […] I failed to find any useful data about pharmacokinetics as well as BE reports of other companies and PARs about drugs with such API. My colleagues failed as well.
You are not alone.
What speaks against a pilot study?
The quality of responses received is directly proportional to the quality of the question asked. 🚮
20,249 posts in 4,261 threads, 1,397 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 22:23 CET
To call the statistician after the experiment is done
may be no more than asking him to perform a postmortem examination:
he may be able to say what the experiment died of.
The Bioequivalence and Bioavailability Forum
is hosted by
Ing. Helmut Schütz